COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS) a pioneering US biotech company developing pharmaceutical cannabis products, is very pleased to report that two former US Attorneys, and the former head of Seattle FBI, are in favor of Washington State Initiative 502 to legalize marijuana.
